Travere Therapeutics, Inc. ( TVTX) Discusses FDA Approval of FILSPARI as First Approved Medicine for FSGS April 13, 2026 6:45 PM EDT ...

While many startups founded prior to the emergence of ChatGPT are struggling to position themselves for the AI era, Vercel, a ...

Cloudflare sees agents and fast, transient containeresque agentic AI as a way that enterprises can capitalise on the ...

Yuri Misnik is the Chief Technology Officer at inDrive, where he leads the company’s global technology strategy. With more than two decades of international experience, Misnik has built and led ...

Discover India's advancements in drone warfare and its implications. Learn how technology is reshaping defense strategies.

Climate disclosure is moving faster than most companies can operationalize. Driven by regulation, procurement requirements, and investor pressure, the current reporting infrastructure remains costly, ...

Travere Therapeutics, Inc., today announced that the U.S. Food and Drug Administration (FDA) has approved FILSPARI® (sparsentan) to reduce proteinuria in adult and pediatric patients aged 8 years and ...

The counterterrorism community has increasingly recognized that extremist actors are using artificial intelligence.

Instead of applying ointment and attaching a bandage, a "smart patch that regulates treatment intensity on its own just by ...